These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33356836)

  • 1. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
    Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
    Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc, Cdk2 and cellular senescence: Old players, new game.
    Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
    Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
    Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
    Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
    Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
    Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
    Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tipping the balance: Cdk2 enables Myc to suppress senescence.
    Hydbring P; Larsson LG
    Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
    Carbone CJ; Graña X; Reddy EP; Haines DS
    Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk2: a key regulator of the senescence control function of Myc.
    Hydbring P; Larsson LG
    Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.
    Högstrand K; Hejll E; Sander B; Rozell B; Larsson LG; Grandien A
    PLoS One; 2012; 7(2):e31366. PubMed ID: 22393362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
    Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
    J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.
    Finch A; Prescott J; Shchors K; Hunt A; Soucek L; Dansen TB; Swigart LB; Evan GI
    Cancer Cell; 2006 Aug; 10(2):113-20. PubMed ID: 16904610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK2 is required by MYC to induce apoptosis.
    Deb-Basu D; Aleem E; Kaldis P; Felsher DW
    Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
    Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
    Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
    Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
    Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
    Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
    Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
    de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
    J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.